This bill directs the Director of the Defense Health Agency to conduct a two-phase study on the prevalence and mortality of cancer among military rotary-wing pilots and aviation support personnel. The initial phase compares cancer occurrence and mortality in covered individuals to similarly aged members of the general population for a defined list of cancers.
If the initial phase finds increased prevalence or mortality for any cancer, the second phase expands the inquiry to identify carcinogenic toxins or other hazardous exposures associated with rotary-wing operations and related service duties. Data used will align with SEER formatting and will be disaggregated by race, gender, and age.
The act defines who is a ‘covered individual,’ and requires reporting to Congress within specified timeframes.
At a Glance
What It Does
Directs a two-phase study by the Defense Health Agency, in coordination with NIH/NCI, to assess cancer prevalence and mortality among military rotary-wing aircrew and aviation support personnel and to identify occupational exposures if risks are found.
Who It Affects
Military rotary-wing aircrew and aviation support personnel who served on/after February 28, 1961 and receive health care benefits, across the Army, Navy, Marine Corps, Air Force, and Space Force.
Why It Matters
Establishes a formal baseline of cancer risk for rotary-wing operations and creates a pathway to identify and quantify occupational exposures, informing defense health policy and veteran care.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The ROTOR Act requires the Defense Health Agency to conduct a two-phase study of cancer among military rotary-wing pilots and aviation support personnel. In the first phase, the Agency, working with the National Institutes of Health and the National Cancer Institute, will determine whether there is an increased prevalence or mortality for a defined list of cancers among covered individuals compared to the general population.
For the cancer case where female comparison is needed, the comparison is made against similarly aged women. The second phase only proceeds if Phase 1 finds an elevated risk; this phase aims to identify carcinogenic toxins or hazardous environmental factors linked to rotary-wing operations and to assess service-related exposures not tied to flight operations, including by mapping service locations and duties.
Data will be formatted in line with SEER standards and disaggregated by race, gender, and age. Data sources include the SEER program, the NDAA 2021 section 750 study, and other relevant DoD research.
Reports are due to Congress at the end of each phase, with definitions clarifying who counts as a ‘covered individual’ and what constitutes a ‘covered Armed Force.’
The Five Things You Need to Know
The study covers 12 cancers: brain, breast, colon/rectal, kidney, lung, melanoma, non-Hodgkin's lymphoma, ovarian, pancreatic, prostate, testicular, and urinary bladder cancers.
Phase 1 determines whether there is increased cancer prevalence or mortality among covered individuals vs. the general population (women-specific comparison where relevant).
Phase 2, triggered by Phase 1 results, identifies carcinogenic toxins, hazardous environments, and certain service duties that may link to cancer, including EMF exposure and non-aviation toxins.
Data are formatted to SEER standards and disaggregated by race, gender, and age, using SEER, NDAA 2021 section 750, and other DoD studies as sources.
Key definitions set who counts as a ‘covered individual’ and specify the scope of the covered Armed Forces and data sources.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
This act may be cited as the Rotary-wing Operator Toxic Occupational Research Act (ROTOR Act). The title signals a focused research mandate on cancer risks among rotary-wing aviation personnel.
Study required
The Director of the Defense Health Agency must conduct a two-phase study in coordination with NIH and NCI. The work involves evaluating cancer prevalence and mortality among covered individuals and establishing a framework for subsequent exposure identification if risks are found.
Initial phase goal
Phase 1 aims to determine, for each cancer listed in subsection (b)(2), whether there is an increased prevalence or mortality among covered individuals compared to similarly aged individuals in the general population (with a female comparator for the female-referenced cancer).
Cancers specified
The cancers specified are brain, breast, colon/rectal, kidney, lung, melanoma, non-Hodgkin’s lymphoma, ovarian, pancreatic, prostate, testicular, and urinary bladder cancers. These were chosen to reflect cancers with potential occupational exposure relevance.
Report on initial phase
Not later than one year after enactment, DHA must submit a report detailing the Phase 1 findings to the appropriate congressional committees, establishing a basis for any subsequent phase.
Second phase
If Phase 1 shows increased prevalence or mortality for any cancer (or for the female cancer in subsection (b)(2)(B)), a Phase 2 will be conducted to identify carcinogenic toxins or hazardous exposures linked to rotary-wing operations, including fumes, fuels, liquids, electromagnetic fields, radar exposure, and related service duties and locations.
Data sources
Data for the study will come from the SEER database, the NDAA 2021 section 750 study, and other relevant DoD research. Data formatting will align with SEER conventions, including disaggregation by race, gender, and age.
Definitions
Key definitions establish who qualifies as 'appropriate congressional committees', what constitutes a 'covered Armed Force', who is a 'covered individual', and what is the 'Surveillance, Epidemiology, and End Results program' reference.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Rotary-wing aircrew and aviation support personnel gain a health research baseline and potential early identification of elevated cancer risks that could guide prevention and screening.
- DoD and Defense Health Agency gain structured data to inform occupational health policy, risk mitigation, and veterans’ healthcare planning.
- NIH and NCI coordinate with DoD to leverage national cancer surveillance capabilities, enhancing cross-sector research.
- Veterans Affairs health system benefits from improved understanding of long-term cancer risk patterns among veterans who served in rotary-wing operations.
- The military medical research community gains data harmonization with SEER standards, improving interoperability of data for future studies.
Who Bears the Cost
- The DoD and Defense Health Agency incur program and personnel costs to design, execute, and maintain the study and data reporting.
- NIH/NCI incur coordination costs and potential contractor support for data integration and analysis.
- Academic and medical research institutions may bear costs related to data processing, privacy protections, and analysis beyond existing contracts.
Key Issues
The Core Tension
The central dilemma is whether to pursue an expansive exposure assessment only when Phase 1 signals risk, potentially delaying actionable insights, versus pursuing broader exposure analysis upfront at the risk of allocating resources to a study that may not find elevated cancer risk.
The ROTOR Act creates a rigorous observational framework to identify associations between rotary-wing service and cancer, but it cannot by itself establish causation. Phase 2 depends on Phase 1 showing elevated risk, which may delay deeper exposure investigations.
The reliance on SEER-like data formatting improves comparability but may still face limitations in capturing all relevant occupational variables, especially for earlier cohorts or non-federal service data. Data privacy, availability, and interagency collaboration will be critical to timely reporting.
Finally, the bill relies on a broad definition of 'covered individual' and 'covered Armed Force,' which governs who is included in the study and who benefits from its findings.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.